Centromere protein U is a potential target for gene therapy of human bladder cancer.

about

Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.

P2860

Q52331241-7715D81E-86B3-416F-B1DE-72E4162FE67D

P2860

Centromere protein U is a potential target for gene therapy of human bladder cancer.

Item

http://www.wikidata.org/entity/Q38693334

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Centromere protein U is a potential target for gene therapy of human bladder cancer.

@en

type

Item

label

Centromere protein U is a potential target for gene therapy of human bladder cancer.

@en

prefLabel

Centromere protein U is a potential target for gene therapy of human bladder cancer.

@en

P1476

Centromere protein U is a potential target for gene therapy of human bladder cancer.

@en

P2093

Beibei Liu

http://www.w3.org/2001/XMLSchema#string

Changyuan Dai

http://www.w3.org/2001/XMLSchema#string

Jiajun Zhang

http://www.w3.org/2001/XMLSchema#string

Qingwen Li

http://www.w3.org/2001/XMLSchema#string

Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Wei Sun

http://www.w3.org/2001/XMLSchema#string

Wenyan Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction

MIM, a potential metastasis suppressor gene in bladder cancer

The constitutive centromere component CENP-50 is required for recovery from spindle damage.

A new mathematical model for relative quantification in real-time RT-PCR

The human CENP-A centromeric nucleosome-associated complex

cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer.

Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma.

CENP-U cooperates with Hec1 to orchestrate kinetochore-microtubule attachment.

P304

735-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2017.5769

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28677729

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5562008

http://www.w3.org/2001/XMLSchema#string

Centromere protein U is a potential target for gene therapy of human bladder cancer.

about

P2860

P2860

Centromere protein U is a potential target for gene therapy of human bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932